Stock UniverseDerived research view · source repositories remain read-only

ICU Medical, Inc. (ICUI)

Life Science Tools / Diagnostics / MedTech · Healthcare / Medical Instruments & Supplies
Score Band
Qualified
Selection Score
36.70
Global Rank
960
Market Cap
3.72B
Latest Close
136.61
RS Composite
-6.34% · G#1849

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
14.23%
3M
3.49%
6M
-5.16%
1Y
4.00%
3Y
-21.89%
5Y
-34.34%
10Y
31.37%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 265.75K · 30-day average: 299.93K · Max drawdown over stored range: -73.82%

Research Snapshot

Relative Strength vs SPX

RS Composite-6.34%
20D RS10.37%
60D RS-6.84%
120D RS-14.20%
Global RS Rank1849 · 44.89% percentile
Qualified+ RS Rank681 · 45.87% percentile
Group ScopeQualified+
Primary RS Rank60 · 57.75% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank70 / 246
Primary Percentile71.95
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-072.16B818.16M43.52M46.34M1.86281.29M133.66M147.63M25M37.93%2.02%2.15%13.04%6.85%288.33M1.26B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$1.8673.6x$86.411.6x$5.9123.1x$11.2712.1x

Shares Diluted: 25M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue1316.3082279.9972259.1262382.0462231.262
Revenue Growth (YoY)3.564%73.212%-0.915%5.441%-6.33%
Gross Profit491.49697.761739.873824.782822.039
Operating Income141.409-3.56847.83697.405109.334
Free Cash Flow198.996-152.4482.308124.6691.804
Free Cash Flow Per Share9.136-6.3873.4175.1123.686
EPS (Diluted) GAAP4.74-3.112368-1.230957-4.830.029707
EPS Growth17.91%3700%3700%3700%3700%
EPS Non-GAAP
Gross Margin37.339%30.604%32.75%34.625%36.842%
Operating Margin10.743%-0.156%2.117%4.089%4.9%
Profit Margin7.835%-3.258%-1.313%-4.941%0.033%
Free Cash Flow Margin15.118%-6.686%3.643%5.233%4.114%
Shares Outstanding (Diluted)21.78123.86824.09124.38824.904
Shares Change (YoY)0.88%9.582%0.934%1.233%2.116%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-07530.23M38.89%13.58M2.56%30.13M5.68%1.2025.18M288.33M1.26Bprocessed
2025 Q42026-02-19540.70M37.54%5.63M1.04%-15.73M-2.91%-0.6225.27M307.96M1.27Bprocessed
2025 Q32025-11-06536.99M37.41%13.72M2.55%-3.40M-0.63%-0.1424.69M299.73M1.31Bprocessed
2025 Q22025-08-07548.87M37.91%10.59M1.93%35.34M6.44%1.4324.71M300.02M1.34Bprocessed
2025 Q12025-05-08604.70M34.75%12.89M2.13%-15.48M-2.56%-0.6324.54M289.70M1.49Bprocessed
2024 Q42025-02-27629.80M36.08%37.69M5.98%n/an/an/a24.49M308.57M1.53Bprocessed
2024 Q32024-11-12589.13M34.77%8.24M1.40%-32.98M-5.60%-1.3524.44M312.51M1.54Bprocessed
2024 Q22024-08-07596.46M34.78%7.69M1.29%-21.41M-3.59%-0.8824.39M302.65M1.55Bprocessed
2024 Q12024-05-07566.65M32.69%-10.65M-1.88%-39.47M-6.97%-1.6324.22M251.42M1.57Bprocessed
2023 Q42024-02-27587.86M29.19%-12.18M-2.07%n/an/an/a24.14M254.22M1.58Bprocessed
2023 Q32023-11-06553.31M33.24%22.85M4.13%7.24M1.31%0.3024.37M197.19M1.59Bprocessed
2023 Q22023-08-07549.31M35.01%2.76M0.50%-9.93M-1.81%-0.4124.07M195.89M1.60Bprocessed
2023 Q12023-05-09568.65M33.77%9.39M1.65%-9.81M-1.73%-0.4124.01M220.95M1.61Bprocessed
2022 Q42023-02-27578.01M30.27%-222.00K-0.04%n/an/an/a23.99M208.78M1.62Bprocessed
2022 Q32022-11-07597.86M31.18%-467.00K-0.08%-13.21M-2.21%-0.5523.91M243.88M1.63Bprocessed
2022 Q22022-08-09561.00M29.87%-48.00K-0.01%-7.47M-1.33%-0.3123.90M255.70M1.64Bprocessed
2022 Q12022-05-09543.12M31.08%-42.16M-7.76%-38.07M-7.01%-1.6123.65M329.43M1.64Bprocessed
2021 Q42022-02-25340.52M37.44%23.82M7.00%n/an/an/a21.92M552.83M850.00Mprocessed
2021 Q32021-11-05336.06M38.03%38.38M11.42%31.08M9.25%1.4321.73M519.49Mn/aprocessed
2021 Q12021-08-04321.68M38.40%34.47M10.72%28.40M8.83%1.3121.70M462.04Mn/aprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.